1) Paruch Kamil et al. Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2
Bioorganic and Medicinal Chemistry Letters, V.17 ,2007, P.6220 - 6223
Код: Выделить всё
http://dx.doi.org/10.1016/j.bmcl.2007.09.0172) Cuny Gregory D.et al. Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors
Bioorganic and Medicinal Chemistry Letters
V. 18, 2008, P.4388 - 4392
Код: Выделить всё
http://dx.doi.org/10.1016/j.bmcl.2008.06.052Chemistry of Heterocyclic Compounds (New York, NY, United States),V.36, 2000, P.281 - 283
Код: Выделить всё
http://dx.doi.org/10.1007/BF022568644) Reynolds et al. CONDENSATIONS OF NITRILES HAVING α-HYDROGEN TO FORM β-IMINONITRILES, CYCLIC TRIMERS, AND SUBSTITUTED 2-HYDROXY-4-AMINOPYRIDINES
Journal of Organic Chemistry, V.16, 1951 P.165,167, 169
Код: Выделить всё
http://dx.doi.org/10.1021/jo01142a0015) Grandberg,I.I.; Krokhina,N.F. Synthesis of a series of 5-aminopyrazoles with potential physiological activity
Pharmaceutical Chemistry Journal,1968, P.12 - 16
Код: Выделить всё
http://dx.doi.org/10.1007/BF00761092